Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Vivani Medical, Inc.

VANI Clue Score31
United States Fiscal year ends December CIK 0001266806 Results filed 13 Aug 2026

What the insiders did Net buying

By person

21 insiders · 271 transactions
1.9×

Adam Mendelsohn holds only 1.9 times base salary in stock. $1.18M of shares against $610.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Adam Mendelsohn last reported holding, valued at $1.26, the price Common Stock was last bought or sold at on the open market here, on 15 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Gregg Williams
Director
$67.59M (189)
—
+$67.59M
178,755,468
—
$225.23M
+159.6%
Alfred E. Mann Living Trust entity
10% owner
—
$7.94M (13)
−$7.94M
0
0.0000%
$0.00
−100.0%
Joachim Eberhard Bolck
10% owner
$239.22K (23)
—
+$239.22K
3,072,894
3.41%
$3.87M
+6.1%
Jonathan Will McGuire
Director
—
$73.81K (9)
−$73.81K
20,469
0.0227%
$25.79K
—
Donald Dwyer
Chief Business Officer
$63.23K (17)
—
+$63.23K
55,000
0.0610%
$69.30K
—
Edward David Randolph
Vice President Manufacturing
—
$51.93K (3)
−$51.93K
22
<0.0001%
$27.72
0.0%
Aaron Mendelsohn
Director
$37.58K (2)
—
+$37.58K
1,813,874
2.01%
$2.29M
+171.4%
Stephen D Okland
Chief Commercial Officer
—
$22.58K (2)
−$22.58K
23,641
0.0262%
$29.79K
0.0%
Brigid Makes
Chief Financial Officer
$14.88K (6)
—
+$14.88K
15,000
0.0166%
$18.90K
—
Robert J. Greenberg
Chairman of Board
—
$3.82K (1)
−$3.82K
172,911
0.1917%
$217.87K
−1.1%
William J Phd Link
Director
—
—
—
4,608,161
5.11%
$5.81M
+2.0%
Adam Mendelsohn
Chief Executive Officer
—
—
—
3,695,573
4.10%
$4.66M
—
Wilford Dean Baker
Director
—
—
—
197,482
0.2189%
$248.83K
—
Matthew J Pfeffer
Director
—
—
—
118,301
0.1311%
$149.06K
+577.5%
Thomas B Miller
Chief Financial Officer
—
—
—
78,354
0.0869%
$98.73K
+617.6%
Gregoire Cosendai
VP Clinical Affairs
—
—
—
23,484
0.0260%
$29.59K
+16.7%
William Patrick Ryan
Chief Operating Officer
—
—
—
2,261
0.0025%
$2.85K
—
Alexandra L. Popoff
Director
—
—
—
2,166
0.0024%
$2.73K
—
John T Blake
Chief Financial Officer
—
—
—
1,754
0.0019%
$2.21K
—
Jessy Dana Dorn
VP-Clin & Scientific Affairs
—
—
—
1,458
0.0016%
$1.84K
0.0%
David Murray Jacques
VP-Research Development
—
—
—
0
0.0000%
$0.00
—